BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 18195148)

  • 21. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.
    Price JL; McKeel DW; Buckles VD; Roe CM; Xiong C; Grundman M; Hansen LA; Petersen RC; Parisi JE; Dickson DW; Smith CD; Davis DG; Schmitt FA; Markesbery WR; Kaye J; Kurlan R; Hulette C; Kurland BF; Higdon R; Kukull W; Morris JC
    Neurobiol Aging; 2009 Jul; 30(7):1026-36. PubMed ID: 19376612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low amyloid-β deposition correlates with high education in cognitively normal older adults: a pilot study.
    Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Kosaka J; Kudo T; Iida H; Kishimoto T
    Int J Geriatr Psychiatry; 2015 Sep; 30(9):919-26. PubMed ID: 25425062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease.
    Ellis KA; Bush AI; Darby D; De Fazio D; Foster J; Hudson P; Lautenschlager NT; Lenzo N; Martins RN; Maruff P; Masters C; Milner A; Pike K; Rowe C; Savage G; Szoeke C; Taddei K; Villemagne V; Woodward M; Ames D;
    Int Psychogeriatr; 2009 Aug; 21(4):672-87. PubMed ID: 19470201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of Regional Brain Structural Differences With Aging, Modifiable Risk Factors for Dementia, and Cognitive Performance.
    Suzuki H; Venkataraman AV; Bai W; Guitton F; Guo Y; Dehghan A; Matthews PM;
    JAMA Netw Open; 2019 Dec; 2(12):e1917257. PubMed ID: 31825506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly.
    Csernansky JG; Wang L; Swank J; Miller JP; Gado M; McKeel D; Miller MI; Morris JC
    Neuroimage; 2005 Apr; 25(3):783-92. PubMed ID: 15808979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease.
    Mori E; Hirono N; Yamashita H; Imamura T; Ikejiri Y; Ikeda M; Kitagaki H; Shimomura T; Yoneda Y
    Am J Psychiatry; 1997 Jan; 154(1):18-24. PubMed ID: 8988953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mild cognitive impairment represents early-stage Alzheimer disease.
    Morris JC; Storandt M; Miller JP; McKeel DW; Price JL; Rubin EH; Berg L
    Arch Neurol; 2001 Mar; 58(3):397-405. PubMed ID: 11255443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging.
    Lieb W; Beiser AS; Vasan RS; Tan ZS; Au R; Harris TB; Roubenoff R; Auerbach S; DeCarli C; Wolf PA; Seshadri S
    JAMA; 2009 Dec; 302(23):2565-72. PubMed ID: 20009056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting the rate of cognitive decline in aging and early Alzheimer disease.
    Adak S; Illouz K; Gorman W; Tandon R; Zimmerman EA; Guariglia R; Moore MM; Kaye JA
    Neurology; 2004 Jul; 63(1):108-14. PubMed ID: 15249619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal changes in cognition in Parkinson's disease with and without dementia.
    Johnson DK; Galvin JE
    Dement Geriatr Cogn Disord; 2011; 31(2):98-108. PubMed ID: 21242691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Process dissociation analyses of memory changes in healthy aging, preclinical, and very mild Alzheimer disease: Evidence for isolated recollection deficits.
    Millar PR; Balota DA; Maddox GB; Duchek JM; Aschenbrenner AJ; Fagan AM; Benzinger TLS; Morris JC
    Neuropsychology; 2017 Oct; 31(7):708-723. PubMed ID: 28206782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Comparative Study of Pathological Outcomes in The University of Manchester Longitudinal Study of Cognition in Normal Healthy Old Age and Brains for Dementia Research Cohorts.
    Robinson AC; Chew-Graham S; Davidson YS; Horan MA; Roncaroli F; Minshull J; du Plessis D; Pal P; Payton A; Pendleton N; Mann DMA
    J Alzheimers Dis; 2020; 73(2):619-632. PubMed ID: 31796669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Oregon brain aging study: neuropathology accompanying healthy aging in the oldest old.
    Green MS; Kaye JA; Ball MJ
    Neurology; 2000 Jan; 54(1):105-13. PubMed ID: 10636134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal pattern of regional brain volume change differentiates normal aging from MCI.
    Driscoll I; Davatzikos C; An Y; Wu X; Shen D; Kraut M; Resnick SM
    Neurology; 2009 Jun; 72(22):1906-13. PubMed ID: 19487648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cardiovascular medications on rate of functional decline in Alzheimer disease.
    Rosenberg PB; Mielke MM; Tschanz J; Cook L; Corcoran C; Hayden KM; Norton M; Rabins PV; Green RC; Welsh-Bohmer KA; Breitner JC; Munger R; Lyketsos CG
    Am J Geriatr Psychiatry; 2008 Nov; 16(11):883-92. PubMed ID: 18978249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hippocampal volume discriminates between normal cognition; questionable and mild dementia in the elderly.
    Wolf H; Grunwald M; Kruggel F; Riedel-Heller SG; Angerhöfer S; Hojjatoleslami A; Hensel A; Arendt T; Gertz H
    Neurobiol Aging; 2001; 22(2):177-86. PubMed ID: 11182467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake.
    Roe CM; Mintun MA; D'Angelo G; Xiong C; Grant EA; Morris JC
    Arch Neurol; 2008 Nov; 65(11):1467-71. PubMed ID: 19001165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging Brains.
    Zeppenfeld DM; Simon M; Haswell JD; D'Abreo D; Murchison C; Quinn JF; Grafe MR; Woltjer RL; Kaye J; Iliff JJ
    JAMA Neurol; 2017 Jan; 74(1):91-99. PubMed ID: 27893874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain size and the compensation of Alzheimer's disease symptoms: a longitudinal cohort study.
    Guo LH; Alexopoulos P; Wagenpfeil S; Kurz A; Perneczky R;
    Alzheimers Dement; 2013 Sep; 9(5):580-6. PubMed ID: 23232272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study.
    Jack CR; Therneau TM; Wiste HJ; Weigand SD; Knopman DS; Lowe VJ; Mielke MM; Vemuri P; Roberts RO; Machulda MM; Senjem ML; Gunter JL; Rocca WA; Petersen RC
    Lancet Neurol; 2016 Jan; 15(1):56-64. PubMed ID: 26597325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.